[(2R,3R,8S,9R,10S,13R,14S,16S,17R)-17-acetyl-3-[(2R,3S,4S,5S,6S)-5-[(2R,3R,4R,5R,6S)-3-[(2R,3S,4S,5R,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-6-(hydroxymethyl)-4-[(2R,3S,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-16-yl] (4R)-4-methyl-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentanoate

Details

Top
Internal ID 529b75ed-5a2c-4782-8b31-a39cf7d30d17
Taxonomy Lipids and lipid-like molecules > Steroids and steroid derivatives > Steroidal glycosides > Steroidal saponins
IUPAC Name [(2R,3R,8S,9R,10S,13R,14S,16S,17R)-17-acetyl-3-[(2R,3S,4S,5S,6S)-5-[(2R,3R,4R,5R,6S)-3-[(2R,3S,4S,5R,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-6-(hydroxymethyl)-4-[(2R,3S,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-16-yl] (4R)-4-methyl-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentanoate
SMILES (Canonical) CC(CCC(=O)OC1CC2C3CC=C4CC(C(CC4(C3CCC2(C1C(=O)C)C)C)O)OC5C(C(C(C(O5)CO)OC6C(C(C(C(O6)CO)O)OC7C(C(C(CO7)O)O)O)OC8C(C(C(C(O8)CO)O)OC9C(C(C(C(O9)CO)O)O)O)O)O)O)COC1C(C(C(C(O1)CO)O)O)O
SMILES (Isomeric) C[C@H](CCC(=O)O[C@H]1C[C@H]2[C@@H]3CC=C4C[C@H]([C@@H](C[C@]4([C@@H]3CC[C@]2([C@H]1C(=O)C)C)C)O)O[C@H]5[C@H]([C@@H]([C@@H]([C@@H](O5)CO)O[C@@H]6[C@@H]([C@@H]([C@@H]([C@@H](O6)CO)O)O[C@@H]7[C@H]([C@H]([C@H](CO7)O)O)O)O[C@@H]8[C@H]([C@H]([C@@H]([C@H](O8)CO)O)O[C@H]9[C@@H]([C@@H]([C@H]([C@@H](O9)CO)O)O)O)O)O)O)CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O
InChI InChI=1S/C62H100O35/c1-21(19-85-55-47(81)43(77)39(73)31(14-63)89-55)5-8-36(71)87-30-12-26-24-7-6-23-11-29(27(69)13-62(23,4)25(24)9-10-61(26,3)37(30)22(2)68)88-57-49(83)45(79)51(35(18-67)93-57)94-60-54(53(42(76)34(17-66)92-60)96-56-46(80)38(72)28(70)20-86-56)97-59-50(84)52(41(75)33(16-65)91-59)95-58-48(82)44(78)40(74)32(15-64)90-58/h6,21,24-35,37-60,63-67,69-70,72-84H,5,7-20H2,1-4H3/t21-,24-,25-,26+,27-,28+,29-,30+,31-,32+,33-,34+,35+,37+,38+,39-,40+,41-,42-,43+,44-,45+,46+,47-,48-,49+,50+,51-,52+,53-,54-,55-,56-,57-,58+,59-,60-,61-,62-/m1/s1
InChI Key ICBHBSRUQCOAJI-STAQWXDBSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C62H100O35
Molecular Weight 1405.40 g/mol
Exact Mass 1404.6045149 g/mol
Topological Polar Surface Area (TPSA) 559.00 Ų
XlogP -7.20
Atomic LogP (AlogP) -9.00
H-Bond Acceptor 35
H-Bond Donor 20
Rotatable Bonds 23

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of [(2R,3R,8S,9R,10S,13R,14S,16S,17R)-17-acetyl-3-[(2R,3S,4S,5S,6S)-5-[(2R,3R,4R,5R,6S)-3-[(2R,3S,4S,5R,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-6-(hydroxymethyl)-4-[(2R,3S,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-16-yl] (4R)-4-methyl-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentanoate

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.7521 75.21%
Caco-2 - 0.8662 86.62%
Blood Brain Barrier + 0.5250 52.50%
Human oral bioavailability - 0.8000 80.00%
Subcellular localzation Mitochondria 0.8375 83.75%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8442 84.42%
OATP1B3 inhibitior + 0.8381 83.81%
MATE1 inhibitior - 0.9812 98.12%
OCT2 inhibitior - 0.5798 57.98%
BSEP inhibitior + 0.9718 97.18%
P-glycoprotein inhibitior + 0.7430 74.30%
P-glycoprotein substrate + 0.7387 73.87%
CYP3A4 substrate + 0.7616 76.16%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8833 88.33%
CYP3A4 inhibition - 0.8852 88.52%
CYP2C9 inhibition - 0.9245 92.45%
CYP2C19 inhibition - 0.9426 94.26%
CYP2D6 inhibition - 0.9538 95.38%
CYP1A2 inhibition - 0.9246 92.46%
CYP2C8 inhibition + 0.7564 75.64%
CYP inhibitory promiscuity - 0.9675 96.75%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 0.9900 99.00%
Carcinogenicity (trinary) Non-required 0.5863 58.63%
Eye corrosion - 0.9904 99.04%
Eye irritation - 0.8988 89.88%
Skin irritation + 0.5512 55.12%
Skin corrosion - 0.9411 94.11%
Ames mutagenesis - 0.7315 73.15%
Human Ether-a-go-go-Related Gene inhibition + 0.8170 81.70%
Micronuclear - 0.7800 78.00%
Hepatotoxicity - 0.7908 79.08%
skin sensitisation - 0.9342 93.42%
Respiratory toxicity + 0.6778 67.78%
Reproductive toxicity + 0.9556 95.56%
Mitochondrial toxicity + 0.6500 65.00%
Nephrotoxicity - 0.8969 89.69%
Acute Oral Toxicity (c) III 0.5383 53.83%
Estrogen receptor binding + 0.8081 80.81%
Androgen receptor binding + 0.7311 73.11%
Thyroid receptor binding + 0.6131 61.31%
Glucocorticoid receptor binding + 0.7665 76.65%
Aromatase binding + 0.6554 65.54%
PPAR gamma + 0.8161 81.61%
Honey bee toxicity - 0.5896 58.96%
Biodegradation - 0.7500 75.00%
Crustacea aquatic toxicity - 0.5355 53.55%
Fish aquatic toxicity + 0.9503 95.03%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 99.46% 96.09%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 99.10% 91.11%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 96.88% 94.45%
CHEMBL5255 O00206 Toll-like receptor 4 94.48% 92.50%
CHEMBL226 P30542 Adenosine A1 receptor 93.28% 95.93%
CHEMBL3137262 O60341 LSD1/CoREST complex 92.27% 97.09%
CHEMBL2581 P07339 Cathepsin D 91.02% 98.95%
CHEMBL1994 P08235 Mineralocorticoid receptor 90.88% 100.00%
CHEMBL253 P34972 Cannabinoid CB2 receptor 89.60% 97.25%
CHEMBL1907602 P06493 Cyclin-dependent kinase 1/cyclin B1 88.98% 91.24%
CHEMBL3359 P21462 Formyl peptide receptor 1 88.72% 93.56%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 88.68% 95.89%
CHEMBL4681 P42330 Aldo-keto-reductase family 1 member C3 88.39% 89.05%
CHEMBL1821 P08173 Muscarinic acetylcholine receptor M4 88.30% 94.08%
CHEMBL1806 P11388 DNA topoisomerase II alpha 88.11% 89.00%
CHEMBL1075094 Q16236 Nuclear factor erythroid 2-related factor 2 87.04% 96.00%
CHEMBL221 P23219 Cyclooxygenase-1 85.74% 90.17%
CHEMBL340 P08684 Cytochrome P450 3A4 84.97% 91.19%
CHEMBL3892 Q99500 Sphingosine 1-phosphate receptor Edg-3 84.86% 97.29%
CHEMBL5608 Q16288 NT-3 growth factor receptor 84.85% 95.89%
CHEMBL4227 P25090 Lipoxin A4 receptor 84.51% 100.00%
CHEMBL2111367 P27986 PI3-kinase p110-alpha/p85-alpha 83.63% 94.33%
CHEMBL1293249 Q13887 Kruppel-like factor 5 83.10% 86.33%
CHEMBL2360 P00492 Hypoxanthine-guanine phosphoribosyltransferase 82.47% 87.38%
CHEMBL4187 Q99250 Sodium channel protein type II alpha subunit 82.33% 95.50%
CHEMBL4478 Q00975 Voltage-gated N-type calcium channel alpha-1B subunit 81.81% 97.14%
CHEMBL3060 Q9Y345 Glycine transporter 2 81.78% 99.17%
CHEMBL5845 P23415 Glycine receptor subunit alpha-1 81.36% 90.71%
CHEMBL4303 P08238 Heat shock protein HSP 90-beta 81.05% 96.77%
CHEMBL211 P08172 Muscarinic acetylcholine receptor M2 80.91% 94.97%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 80.64% 95.56%
CHEMBL4581 P52732 Kinesin-like protein 1 80.15% 93.18%
CHEMBL3004 P33527 Multidrug resistance-associated protein 1 80.04% 96.37%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Cestrum nocturnum

Cross-Links

Top
PubChem 163189770
LOTUS LTS0202438
wikiData Q105110885